Oral dabigatran etexilate Vs. Subcutaneous enoxoparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. - Eriksson,BI.; Dahl,OE.; Rosencher,N. (J Thromb Haemost, 2007)